Latest filing published 19 Aug 2026 for Corona Remedies, €1,411.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Ranjanben Kirtisinh Parmar: trading record in brief
All filings by Ranjanben Kirtisinh Parmar on record concern Corona Remedies. The record holds 2 filings, all for trades on 19 August 2026.
The open-market record is one-sided, with 2 purchases worth €3,128 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 19 August 2026 with an open-market purchase (€1,411) in Corona Remedies. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ranjanben Kirtisinh Parmar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 75 shares@ ₹2,089.70EquityMarket PurchaseSEBI:faba5218e01f9ced0cb88ae6f2ccd8b06c8b4fd8Canonical exit: 17 Nov 2026 (T+90)
- 90 shares@ ₹2,119.90EquityMarket PurchaseSEBI:9070a18a71e95b10bc42d41c1c30bfe944635c2fCanonical exit: 17 Nov 2026 (T+90)
2 of 2 declarations